Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 309, Issue 7, 2015, Pages G590-G601

  Sawin, Emily A ^a   De Wolfe, Travis J ^a   Aktas, Busra ^a   Stroup, Bridget M ^a   Murali, Sangita G ^a   Steele, James L ^a   Ney, Denise M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cytokines; Inflammatory bowel disease; Phenylketonuria; Sialic acid; Sulfate reducing bacteria

Indexed keywords

BUTYRIC ACID; CASEIN; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; PROPIONIC ACID; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; CASEINOMACROPEPTIDE; CYTOKINE; PEPTIDE FRAGMENT; PREBIOTIC AGENT; VOLATILE FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTEROIDETES; CONTROLLED STUDY; DESULFOVIBRIO; DNA EXTRACTION; FECES MICROFLORA; FEMALE; FIRMICUTES; FLOW CYTOMETRY; GAS CHROMATOGRAPHY; IMMUNE RESPONSE; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOBACTERIA; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BLOOD; C57BL MOUSE; CECUM; DRUG EFFECTS; FECES; METABOLISM; MICROBIOLOGY; PHENYLKETONURIAS;

ANIMALS; CASEINS; CECUM; CYTOKINES; DESULFOVIBRIO; FATTY ACIDS, VOLATILE; FECES; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL MICROBIOME; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PHENYLKETONURIAS; PREBIOTICS;

EID: 84943177844     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00211.2015     Document Type: Article

References (64)

1. Aimulis WR. Bioactive properties of milk proteins with particular focus on anticariogenesis. J Nutr 134, Suppl 4: S989-S995, 2004.
2. Beucher S, Levenez F, Yvon M, Corring T. Effects of gastric digestive products from casein on CCK release by intestinal cells in rat. J Nutr Biochem 5: 578-584, 1994.
3. Brody EP. Biological activities of bovine glycomacropeptide. Br J Nutr 84, Suppl 1: 39-46, 2000.
4. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Gonzalez PA, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nature Med 7: 335-336, 2010.
5. Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Boynard M, Perrotin P, Guillet R, Jolles P, Fiat AM. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80: 155-165, 1998.
6. Chen Q, Cao J, Jia Y, Liu W, Yan Y, Pang G. Modulation of mice fecal microbiota by administration of casein glycomacropeptide. Microbiol Res 3: 3, 2012.
7. Claustre J, Toumi F, Trompette A, Jourdan G, Guignard H, Chayvialle JA, Plaisancié P. Effects of peptides derived from dietary proteins on mucus secretion in rat jejunum. Am J Physiol Gastrointest Liver Physiol 283: G521-G528, 2002.
8. Daddaoua A, Puerta V, Zarzuelo A, Suárez MD, de Medina FS, Martínez-Augustin O. Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr 135: 1164-1170, 2005.
9. de Carcer DA, Cuiv PO, Wang T, Kang S, Worthley D, Whitehall V, Gordon I, McSweeney C, Leggett B, Morrison M. Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon. ISME J 5: 801-809, 2011.
10. de Medina FS, Daddaoua A, Requena P, Capitán-Cañadas F, Zarzuelo A, Suárez MD, Martínez-Augustin O. New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. Proc Nutr Soc 69: 454-462, 2010.
11. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72: 5069-5072, 2006.
12. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature 487: 104-108, 2012.
13. Dray S, Dufour AB. The ade4 package: implementing the duality diagram for ecologist. J Stat Softw 22: 1-20, 2007.
14. Etzel MR. Manufacture and use of dairy protein fractions. J Nutr 134: 996S-1002S, 2004.
15. Faure M, Mettraux C, Moennoz D, Godin J, Vuichoud J, Rochat F, Breuillé D, Obled C, Corthésy-Theulaz I. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr 136: 1558-1564, 2006.
16. Faure M, Moënnoz D, Montigon F, Mettraux C, Breuillé D, Ballèvre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr 135: 486-491, 2005.
17. Florin THJ, Neale G, Goretski S, Cummings JH. The sulfate content of foods and beverages. J Food Comp Analysis 6: 140-151, 1993.
18. Food and Drug Administration. Guidance for industry: frequently asked questions about medical foods (2nd ed.) (Online). Washington DC: US Food and Drug Administration, 2013. http://www.fda.gov/food/guidanceregulation/ guidancedocumentsregulatoryinformation/ [July 2015].
19. French EA, Bertics SJ, Armentano LE. Rumen and milk odd-and branched-chain fatty acid proportions are minimally influenced by ruminal volatile fatty acid infusions. J Dairy Sci 95: 2015-2026, 2012.
20. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 46937331: 543-547, 2011.
21. Gibson GR. Physiology and ecology of the sulphate-reducing bacteria. J Appl Bacteriol 69: 769-797, 1990.
22. Gibson GR, Roberfroid M, eds. Handbook of Prebiotics. Boca Raton, FL: CRC, 2008.
23. Hamilton MK, Boudry G, Lemay DG, Raybould HE. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol 308: G840-G851, 2015.
24. Hansen KE, Ney DM. A systematic review of bone mineral density and fractures in phenylketonuria. J Inherit Metab Dis 37: 875-880, 2014.
25. Harding CO, Gillingham MB, Bird A, Koeberl DD. Complete correction of hyperphenylalaninemia following liver-directed, AAV2/8-mediated gene therapy in murine phenylketonuria. Gene Ther 13: 457-462, 2006.
26. Hennermann JB, Roloff S, Gellermann J, Vollmer I, Windt E, Vetter B, Plöckinger U, Mönch E, Querfeld U. Chronic kidney disease in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis 36: 747-756, 2013.
27. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 53: 1479-1484, 2004.
28. Kawasaki Y, Isoda H, Tanimoto M, Dosako S, Idota T, Ahiko K. Inhibition by lactoferrin and κ-casein glycomacropeptide of binding of cholera toxin to its receptor. Biosci Biotechnol Biochem 56: 195-198, 1992.
29. Kelleher SL, Chatterton D, Nielsen K, Lönnerdal B. Glycomacropeptide and α-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am J Clin Nutr 77: 1261-1268, 2003.
30. LaClair CE, Ney DM, MacLeod EL, Etzel MR. Purification and use of glycomacropeptide for nutritional management of phenylketonuria. J Food Sci 74: E199-E206, 2009.
31. López-Posadas R, Requena P, González R, Suárez MD, Zarzuelo A, de Medina FS, Martínez-Augustin O. Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. J Nutr 140: 2014-2019, 2010.
32. McDonald JD, Bode VC, Dove WF, Shedlovsky A. Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci 87: 1965-1967, 1990.
33. Mills DJS, Tuohy KM, Booth J, Buck M, James M, Crabbe C, Gibson GR, Ames JM. Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. J Appl Microbiol 105: 706-714, 2008.
34. National Research Council. Nutrient Requirements of Laboratory Animals (4th rev. ed.). Washington, DC: National Academy of Sciences, National Research Council, Board on Agriculture, Committee on Animal Nutrition, 1995.
35. Ney DM, Blank RD, Hansen KE. Advances in the nutritional and pharmacological management of phenylketonuria. Curr Opin Clin Nutr Metab Care 17: 61-68, 2014.
36. Ohlsson C, Sjögren K. Effects of the gut microbiota on bone mass. Trends Endocrinol Metab 26: 69-74, 2015.
37. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990.
38. Ortega-González M, Capitán-Cañadas F, Requena P, Ocón B, Romero-Calvo I, Aranda C, Suárez MD, Zarzuelo A, de Medina FS, Martínez-Augustin O. Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis. Br J Nutr 111: 1202-1212, 2014.
39. Otani H, Monnai M, Kawasaki Y, Kawakami H, Tanimoto M. Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine κ-caseinoglycopeptides having different carbohydrate chains. J Dairy Res 62: 349-357, 1995.
40. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46: 64-72, 2000.
41. Pitcher MCL, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 39: 1-4, 1996.
42. Poppitt SD, Strik CM, McArdle BH, McGill A, Hall RS. Evidence of enhanced serum amino acid profile but not appetite suppression by dietary glycomacropeptide (GMP): a comparison of dairy whey proteins. J Am Coll Nutr 32: 177-186, 2013.
43. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
44. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
45. Requena P, Daddaoua A, Guadix E, Zarzuelo A, Suárez MD, De Medina FS, Martínez-Augustin O. Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kB signal transduction pathways. Br J Pharmacol 157: 1232-1240, 2009.
46. Requena P, Daddaoua A, Martínez-Plata E, González M, Zarzuelo A, Suárez MD, de Medina FS, Martínez-Augustin O. Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. Br J Pharmacol 154: 825-832, 2008.
47. Requena P, González R, López-Posadas R, Abadía-Molina A, Suárez MD, Zarzuelo A, de Medina FS, Martínez-Augustin O. The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes. Biochem Pharmacol 79: 1797-1804, 2010.
48. Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 305: G529-G541, 2013.
49. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watztl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco M, Léotoing L, Wittrant Y, Delzenne N, Cani P, Neyrinck A, Meheust A. Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl 2: S1-S63, 2010.
50. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104: 802-809, 1993.
51. Rogers QR, Harper AE. Amino acid diets and maximal growth in the rat. J Nutr 87: 267-273, 1965.
52. Romagnani S. T-cell subsets (Th1 versus Th2). Annals Allergy Asthma Immun 85: 9-21, 2000.
53. Rowan F, Docherty NG, Murphy M, Murphy B, Coffey JC, O'Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum 53: 1530-1536, 2010.
54. Sawin EA, Murali SG, Ney DM. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pahenu2 mice. Mol Gene Metab 111: 452-461, 2014.
55. Schoenborn JR, Wilson CB. Regulation of interferon▫γ during innate and adaptive immune responses. Adv Immunol 96: 41-101, 2007.
56. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81: 288-302, 1996.
57. Solverson P, Murali SG, Brinkman AS, Nelson DW, Clayton MK, Yen CE, Ney DM. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria. Am J Physiol Endocrinol Metab 302: E885-E895, 2012.
58. Solverson P, Murali SG, Litscher SJ, Blank RD, Ney DM. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet. PloS One 7: e45165, 2012.
59. Sprong RC, Schonewille AJ, Van der Meer R. Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota. J Dairy Sci 93: 1364-1371, 2010.
60. Supelco. Analyzing fatty acids by packed column gas chromatography. Technical Bulletin 856B. St. Louis, MO: Sigma-Aldrich, 1998.
61. Thomä-Worringer C, Sørensen J, López-Fandiño R. Health effects and technological features of caseinomacropeptide. Int Dairy J 16: 1324-1333, 2006.
62. Van Calcar SC, Ney DM. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino acid-based medical foods for nutrition management of phenylketonuria. J Acad Nutr Dietetics 112: 1201-1210, 2012.
63. Veldhorst MAB, Nieuwenhuizen AG, Hochstenbach-Waelen A, Westerterp KR, Engelen MPKJ, Brummer RJM, Deutz NEP, Westerterp-Plantenga MS. Effects of complete whey-protein breakfasts versus whey without GMP-breakfasts on energy intake and satiety. Appetite 52: 388-395, 2009.
64. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Ann Rev Nutr 29: 177-222, 2009.